세계의 NGS 샘플 조제 시장(2023-2030년)

Global NGS Sample Preparation Market Size, Share &Trends Analysis Report by Product Class(Reagent and Consumables, and Workstations), by Application (Diagnostics, Drug Discovery, and Others)and by End-User (Hospitals and Clinics, Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, and Others), Forecast Period (2023-2030)

The global NGS sample preparation market is anticipated to grow at a significant CAGR of 14.7% during the forecast period (2023-2030).The market's growth is attributed to the high demand for genome sequencing due to decreasing sequencing costs. Continuous efforts to minimize the overall cost of sequencing have aided in the growth of the NGS Sample Preparation Market. Streamlining library preparation methods helps to considerably reduce costs. For instance, in November 2023, New England Biolabs (NEB) released the NEBNextUltraExpress DNA and RNA Library Prep Kits for next generation sequencing on the Illumina platform. New kits offer a faster, easier workflow for generating high-quality libraries, allowing RNA and DNA library prep in a single day or two hours, with automation-friendly workflows and minimal consumable waste. However, the easy availability of low cost alternative may restrain the market growth.

Segmental Outlook

The global NGS sample preparation market is segmented on the product class, application and end-user. Based on the product class, the market is sub-segmented into reagent and consumables, and workstations. Based on the application, the market is sub-segmented into diagnostics, drug discovery, and others. Furthermore, on the basis of end-user, the market is sub-segmented into hospitals and clinics, academic and research institutions, pharmaceutical and biotechnology companies, and others. The diagnostics subcategory is expected to capture a significant portion of the market share within the product class segment. This is attributed to the growing demand for NGS-based clinical diagnostics and the increasing prevalence of genetic diseases including cancer.

The Workstations Sub-Segment is Anticipated to Hold a Considerable Share of the global NGS Sample Preparation Market

Among the product class, the workstations sub-segment is expected to hold a considerable share of the global NGS Sample Preparation market. The segmental growth is attributed to the increased demand for automation in laboratories. Laboratories are rapidly adopting automated solutions in order to handle the increasing volume of samples, improve efficiency, and reduce hands-on time. Fontus workstations satisfy the demand by providing automated liquid handling solutions. For instance, in July 2023, Revvity launched the Fontus Automated Liquid Handling Workstation, a next-generation liquid handler that incorporates the greatest technology from company's previous platforms and is designed to provide easier and faster workflows that provide better results for next generation sequencing(NGS) and diagnostic research applications.

Regional Outlook

The global NGS sample preparation market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to exhibit fastest CAGR during the forecast period. The rising use of NGS technology in developing countries such as China and India, in addition to increasing demand for NGS-based research in a variety of fields are key factors contributing to the regional market growth.

The North America Holds Considerable Share in the Global NGS Sample Preparation Market

Among all regions, the North America holds considerable share in the global market. Regional growth is attributed to the sample standardization challenges. Sample variability due to varied origins is a challenges for standardization. It is essential to develop robust protocols that account for varied sample properties in order to achieve accurate pooling and subsequent read separation. According to the BMC Genomics, in August 2022,DNA and RNA sequencing is a widely used procedure for identifying diseases, understanding cell regulation, and understanding cell replication dynamics. Despite significant price reductions in the last decade, the final library sequencing only covers 20% of the total costs of a 10 million read sequencing project.

Automation could be an option for future cost reduction, but samples are not standardized due to their different origins. An approach to pool samples of different organisms and separate DNA/RNA reads bioinformatically after pooled sample preparation and sequencing could reduce total costs for DNA and RNA sequencing to 50%. This study investigates the limits of sample pooling for high-quality genomics and transcriptomics applications, considering error rates and evolutionary distances.

Market Players Outlook

The major companies serving the NGS sample preparation market includes Bio-Rad Laboratories, Inc., Danaher Corp, DNASTAR, Huawei Technologies Co. Ltd, and Illumina, Inc. among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2023, QIAGEN acquired of Verogen, strengthening leadership\ in Human ID / the use of next-generation sequencing (NGS) technologies to drive the future of human identification (HID) and forensic investigation. It offers DNA collection, preparation kits, genetic testing analysis, and workflow automation products for forensic science laboratories and criminal investigators globally.

The Report Covers:

• Market value data analysis of 2022 and forecast to 2030.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global NGS sample preparation market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies. Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. Agilent Technologies, Inc.
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. At F. Hoffmann-La Roche Ltd.
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. BGI Genomics Co., Ltd.,
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global NGS Sample Preparation Market by Product Class
  • 4.1.1. Reagent and Consumables
  • 4.1.2. Workstations
• 4.2. Global NGS Sample Preparation Market by APPLICATION
  • 4.2.1. Diagnostics
  • 4.2.2. Drug Discovery
  • 4.2.3. Others (Transcriptomic Analysis, Metagenomics and Microbiome Studies, and Cancer Genomics)
• 4.3. Global NGS Sample Preparation Market by End-User
  • 4.3.1. Hospitals and Clinics
  • 4.3.2. Academic and Research Institutions
  • 4.3.3. Pharmaceutical and Biotechnology Companies
  • 4.3.4. Others (Government and Regulatory Agencies, and Agricultural and Environmental Organizations)

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. Bio-Rad Laboratories, Inc.
• 6.2. Danaher Corp.
• 6.3. DNASTAR
• 6.4. Eurofins Scientific SE
• 6.5. Genomatix GmbH
• 6.6. Helix OpCo, LLC.
• 6.7. Huawei Technologies Co. Ltd
• 6.8. Illumina, Inc.
• 6.9. Integrated DNA Technologies, Inc.
• 6.10. Macrogen Inc.
• 6.11. PerkinElmer U.S. LLC
• 6.12. QIAGEN GmbH
• 6.13. Thermo Fisher Scientific Inc.